Allerphenex

Product NDC
44911-0355
Requested package NDC
44911-0355-1
11-digit product format
449110355
Labeler code
44911
Product ID
44911-0355_9f8d1f0d-2729-48d0-bdd1-57d137d2893f
Type
HUMAN OTC DRUG
Nonproprietary name
Acetylcholine Chloride, Acetaldehyde, Adrenalinum, Caffeic Acid, Candida Albicans, Chlorogenic Acid, Cinnamic Acid, Coumarinum, Cysteinum, Gallicum Acidum, Hepar Suis, Histaminum Hydrochloricum, Indolum, Malvin, Mannan, Menadione, Norepinephrine, Octopamine (Hydrochloride), Pancreas Suis, Phenyl Isothiocyanate, Phloridzinum, Quercetin, Salsolinol, Serotonin (Hydrochloride)
Dosage form
LIQUID
Route
ORAL
Labeler
Energique, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2016-04-20
Marketing end
2024-02-25
Substance
ACETALDEHYDE; ACETYLCHOLINE CHLORIDE; CAFFEIC ACID; CANDIDA ALBICANS; CHLOROGENIC ACID; CINNAMIC ACID; COUMARIN; CYSTEINE; EPINEPHRINE; GALLIC ACID MONOHYDRATE; HISTAMINE DIHYDROCHLORIDE; INDOLE; MALVIN; MENADIONE; NOREPINEPHRINE; OCTOPAMINE HYDROCHLORIDE; PHENYL ISOTHIOCYANATE; PHLORIZIN; PORK LIVER; QUERCETIN; SALSOLINOL HYDROCHLORIDE; SEROTONIN HYDROCHLORIDE; SUS SCROFA PANCREAS; YEAST MANNAN
Active strength
200 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamine [EPC], Catecholamines [CS], Catecholamines [CS], Cell-mediated Immunity [PE], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage44911-035544911-0355-1DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 13 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2021-12-27 23:28 UTC · source 2021-12-27IInactivated by FDA8dfbde2a14a4…c9ff85d89658…

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
44911-0355-12022-03-10C16284748780-1ba0f9c33-4cee-a910-e053-dadaa90a0b85Drug Facts:
44911-0355-12021-01-29C16284748780-1ba0f9c33-4cee-a910-e053-dadaa90a0b85Drug Facts:

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
44911-0355-14491103550130 mL in 1 BOTTLE, DROPPER (44911-0355-1) 30 ml2016-04-202024-02-25NoNoCurrent